CHINA PHARMA HOLDINGS, INC. (CPHI) Operating income 2016–2025
CHINA PHARMA HOLDINGS, INC. (CPHI) annual operating income history from SEC filings — each fiscal year as reported.
-$3.2MFY2025 · since FY2016: -$8.2M → -$3.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.2M | +29.4% |
| FY2024 | -$4.6M | -66.8% |
| FY2023 | -$2.8M | +22.5% |
| FY2022 | -$3.5M | -24.1% |
| FY2021 | -$2.9M | -10.9% |
| FY2020 | -$2.6M | +87.4% |
| FY2019 | -$20.4M | -95.3% |
| FY2018 | -$10.4M | +44.1% |
| FY2017 | -$18.7M | -129.0% |
| FY2016 | -$8.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CPHI financial trends
CPHI RevenueCPHI Net incomeCPHI Net marginCPHI Gross profitCPHI Gross marginCPHI Operating marginCPHI Operating cash flowCPHI Free cash flowCPHI Capital expendituresCPHI Return on equityCPHI Stock buybacksCPHI Dividends paidCPHI Total assetsCPHI Total liabilitiesCPHI Shareholders’ equityCPHI overview →